Serial circulating tumor DNA to predict early recurrence in patients with hepatocellular carcinoma: a prospective study

We studied the value of circulating tumor DNA (ctDNA) in predicting early postoperative tumor recurrence and monitoring tumor burden in patients with hepatocellular carcinoma (HCC). Plasma‐free DNA, germline DNA, and tissue DNA were isolated from 41 patients with HCC. Serial ctDNAs were analyzed by...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui‐Qi, Liu, Wei‐Ren, Tang, Zheng, Qu, Wei‐Feng, Fang, Yuan, Jiang, Xi‐Fei, Song, Shu‐Shu, Wang, Han, Tao, Chen‐Yang, Zhou, Pei‐Yun, Huang, Run, Gao, Jun, Sun, Hai‐Xiang, Ding, Zhen‐Bin, Peng, Yuan‐Fei, Dai, Zhi, Zhou, Jian, Fan, Jia, Shi, Ying‐Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763657/
https://www.ncbi.nlm.nih.gov/pubmed/34543520
http://dx.doi.org/10.1002/1878-0261.13105

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8763657/
https://www.ncbi.nlm.nih.gov/pubmed/34543520
http://dx.doi.org/10.1002/1878-0261.13105

Ejemplares similares